Belpointe Asset Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$498K Buy
+7,430
New +$543K 0.02% 725
2025
Q4
Sell
-5,566
Closed -$351K 1048
2025
Q3
$351K Sell
5,566
-25
-0.4% -$1.75K 0.01% 742
2025
Q2
$417K Buy
5,591
+480
+9% +$37.7K 0.02% 643
2025
Q1
$450K Buy
5,111
+862
+20% +$81.4K 0.02% 595
2024
Q4
$435K Sell
4,249
-421
-9% -$43.2K 0.03% 544
2024
Q3
$523K Buy
4,670
+969
+26% +$96.9K 0.03% 491
2024
Q2
$363K Sell
3,701
-114
-3% -$11.3K 0.03% 531
2024
Q1
$382K Sell
3,815
-170
-4% -$15K 0.03% 511
2023
Q4
$358K Sell
3,985
-1,192
-23% -$95K 0.03% 468
2023
Q3
$397K Buy
5,177
+2,760
+114% +$229K 0.04% 398
2023
Q2
$202K Sell
2,417
-2,397
-50% -$195K 0.02% 570
2023
Q1
$406K Buy
4,814
+745
+18% +$64K 0.02% 634
2022
Q4
$331K Buy
4,069
+337
+9% +$27.2K 0.02% 692
2022
Q3
$265K Buy
3,732
+619
+20% +$55.6K 0.02% 729
2022
Q2
$279K Sell
3,113
-308
-9% -$31.9K 0.02% 706
2022
Q1
$383K Buy
3,421
+550
+19% +$64.4K 0.02% 628
2021
Q4
$347K Buy
2,871
+49
+2% +$5.45K 0.02% 647
2021
Q3
$284K Sell
2,822
-143
-5% -$15.8K 0.02% 705
2021
Q2
$346K Buy
2,965
+781
+36% +$93.8K 0.02% 622
2021
Q1
$241K Buy
2,184
+557
+34% +$60.5K 0.02% 681
2020
Q4
$163K Buy
1,627
+197
+14% +$18.3K 0.01% 770
2020
Q3
$112K Sell
1,430
-55
-4% -$4.14K 0.01% 737
2020
Q2
$103K Buy
+1,485
New +$93.6K 0.01% 719
2020
Q1
Sell
-2,752
Closed -$218K 668
2019
Q4
$218K Buy
2,752
+1,088
+65% +$83.7K 0.03% 510
2019
Q3
$123K Sell
1,664
-150
-8% -$10.8K 0.02% 610
2019
Q2
$141K Sell
1,814
-650
-26% -$49.4K 0.03% 497
2019
Q1
$187K Buy
2,464
+700
+40% +$55.6K 0.04% 315
2018
Q4
$129K Sell
1,764
-66
-4% -$5.26K 0.03% 428
2018
Q3
$175K Sell
1,830
-4,624
-72% -$458K 0.03% 485
2018
Q2
$645K Sell
6,454
-385
-6% -$40.6K 0.18% 109
2018
Q1
$722K Buy
+6,839
New +$691K 0.21% 91
2017
Q4
Sell
-7,283
Closed -$659K 470
2017
Q3
$659K Buy
+7,283
New +$620K 0.15% 141

Other funds holding EMN

Belpointe Asset Management's EMN Position: Q2 2026 in Review

Belpointe Asset Management opened a new position in Eastman Chemical (EMN) in Q2 2026: 7,430 shares worth $498K. The stake represents 0.02% of the portfolio and ranks #725 among its holdings. This is a return to the name: Belpointe Asset Management previously reported a position in EMN as recently as Q3 2025.

Belpointe Asset Management first reported a position in EMN in Q3 2017 and has held it in 32 quarters since. The position peaked at $722K in Q1 2018. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Belpointe Asset Management held 7,430 shares of Eastman Chemical worth $498K as of Q2 2026.
  • Eastman Chemical was a new Belpointe Asset Management position in Q2 2026.
  • Eastman Chemical made up 0.02% of Belpointe Asset Management's portfolio in Q2 2026, its #725 holding.
  • Belpointe Asset Management first reported a position in Eastman Chemical in Q3 2017 and has held it in 32 quarters since.
  • Belpointe Asset Management's Eastman Chemical position peaked at $722K in Q1 2018.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.